Plus Therapeutics Expands Collaboration with Piramal Pharma Solutions to Meet Increase in Investigational Drug Demand for Ongoing and Planned Clinical Trials

    © 2024 Piramal Enterprises Ltd.

    Piramal Pharma Solutions Supports Theracosbio With Integrated Drug Substance/drug Product Program For Bexagliflozin

    Piramal Pharma Solutions Announces Production Of First Batches At New Api Facility In Riverview, Michigan

    Piramal Pharma Solutions Announces Winner of its September 2022 Award for Excellence in Patient Centricity

    Yapan Bio Adds New Process Development Facility; Expands Capacity and Capabilities in Large Molecule Therapeutics

    Piramal Pharma Solutions Launches ADCelerate, a Rapid, Integrated Approach to Taking ADCs to IND

    Piramal Pharma Solutions Holds Grand Opening Ceremony for New API Plant at Aurora, Canada Manufacturing Site

    Piramal Pharma Solutions Appoints Herve Berdou as Chief Operating Officer

    Piramal Pharma Solutions Expands API Capabilities at Digwal; Applies Operational Excellence Tools to Release Capacity

    Piramal Pharma Solutions Upgrades Oral Solid Dose Capabilities with New Production Block at Pithampur Site